Abstract:The development of near-infrared (NIR) laser triggered phototheranostics for multimodal imaging-guided combination therapy is highly desirable. However, multiple laser sources, as well as inadequate therapeutic efficacy, impede the application of phototheranostics. Here, we develop an all-in-one theranostic nanoagent PEGylated x NPs (DCDMs) with a flower-like structure fabricated by coating uniformly sized down-conversion nanoparticles (DCNPs) with dendritic mesoporous silica (DMSN) and then loading the ultrasmall oxygen-deficient molybdenum oxide nanoparticles (MoOx NPs) inside through an electrostatic interaction. Owing to the doping of Nd ions, when excited by an 808 nm laser, DCNPs emit bright NIR-II emissions (1060 and 1300 nm), which have characteristic high spatial resolution and deep tissue penetration. In terms of treatment, MoOx NPs could be specifically activated by excessive hydrogen peroxide (H2O2) in the tumor microenvironment, thus generating 1O2via the Russell mechanism. In addition, the excessive glutathione (GSH) in the tumor cells could be depleted through the Mo-mediated redox reaction, thus effectively decreasing the antioxidant capacity of tumor cells. Importantly, the excellent photothermal properties (photothermal conversion efficiency of 51.5% under an 808 nm laser) synergistically accelerate the generation of 1O2. This cyclic redox reaction of molybdenum indeed ensured the high efficacy of tumor-specific therapy, leaving the normal tissues unharmed. MoOx NPs could also efficiently catalyze tumor endogenous H2O2 into a considerable amount of O2 in an acidic tumor microenvironment, thus relieving hypoxia in tumor tissues. Moreover, the computed tomography (CT) and T1-weighted magnetic resonance imaging (MRI) effect from Gd3+ and Y3+ ions make DCNPs act as a hybrid imaging agent, allowing comprehensive analysis of tumor lesions. Both in vitro and in vivo experiments validate that such an "all-in-one" nanoplatform possesses desirable anticancer abilities under single laser source irradiation, benefiting from the NIR-II fluorescence/CT/MR multimodal imaging-guided photothermal/chemodynamic synergistic therapy. Overall, our strategy paves the way to explore other noninvasive cancer phototheranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c17923?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c17923</a>.Experimental methods, HRTEM images, XRD patterns, N2 adsorption–desorption isotherms, pore size distribution, extinction coefficient, photostability and colloidal stability, ESR spectra, schematic illustration of the Russell mechanism, oxygen generation, cell viability, line profiles of CT and MRI values, photothermal behavior under a 1064 nm laser, digital photo of tumors harvested from different groups, H&E stained photographs of major organs, and TEM images of DCDMs after biodegradation (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c17923/suppl_file/am0c17923_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Site-Selective Photosynthesis of Ag–AgCl@Au Nanomushrooms for NIR-II Light-Driven O 2 - and O 2 •– -Evolving Synergistic Photothermal Therapy against Deep Hypoxic Tumors

Site-Selective Photosynthesis of Ag–AgCl@Au Nanomushrooms for NIR-II Light-Driven O2- and O2•–-Evolving Synergistic Photothermal Therapy Against Deep Hypoxic Tumors

Multifunctional MnO2/Ag3SbS3 Nanotheranostic Agent for Single-Laser-Triggered Tumor Synergistic Therapy in the NIR-II Biowindow

Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging

Near-Infrared Upconversion Mesoporous Tin Oxide Bio-Photocatalyst for H 2 O 2 -Activatable O 2 -Generating Magnetic Targeting Synergetic Treatment

NIR‐II Driven Plasmon‐Enhanced Catalysis for a Timely Supply of Oxygen to Overcome Hypoxia‐Induced Radiotherapy Tolerance

Activatable NIR‐II Plasmonic Nanotheranostics for Efficient Photoacoustic Imaging and Photothermal Cancer Therapy

Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect

Smart NIR-Light-Mediated Nanotherapeutic Agents for Enhancing Tumor Accumulation and Overcoming Hypoxia in Synergistic Cancer Therapy.

pH-responsive Ag<sub>2</sub>S nanodots loaded with heat shock protein 70 inhibitor for photoacoustic imaging-guided photothermal cancer therapy

Dual-response Oxygen-Generating MnO2 Nanoparticles with Polydopamine Modification for Combined Photothermal-Photodynamic Therapy

Near-infrared photosensitizers adaptive to tumor hypoxic microenvironment for synergistic photothermal-photodynamic and immunotherapy

Spatiotemporally Controlled O2 and Singlet Oxygen Self-Sufficient Nanophotosensitizers Enable the in Vivo High-Yield Synthesis of Drugs and Efficient Hypoxic Tumor Therapy

Light-activated oxygen self-supplied starving therapy in near-infrared (NIR) window and adjuvant hyperthermia-induced tumor ablation with an augmented sensitivity

An endogenous oxygen self-supplied nanoplatform with GSH-depleted and NIR-II triggered electron–hole separation for enhanced photocatalytic anti-tumor therapy

High Aspect Ratio Plasmonic Au/Ag Nanorods-Mediated NIR-II Photothermally Enhanced Nanozyme Catalytic Cancer Therapy.

Biodegradable Multifunctional Nanotheranostic Based on Ag 2 S-Doped Hollow BSA-SiO 2 for Enhancing ROS-Feedback Synergistic Antitumor Therapy

High‐Performance NIR‐II Fluorescent Type I/II Photosensitizer Enabling Augmented Mild Photothermal Therapy of Tumors by Disrupting Heat Shock Proteins

An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.

Intelligent Nanotransducer for Deep-Tumor Hypoxia Modulation and Enhanced Dual-Photosensitizer Photodynamic Therapy